Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Charbel Issa

Showing results (211-220 of 231) with videos related to

Pageof 24
Sort By:
Eye (London, England)|October 11, 2024
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedemaGrace A Borchert, Christine A Kiire, Niamh M Stone, et al.
JAMA Ophthalmology|May 26, 2018
Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis PigmentosaPeter Charbel Issa, Peggy Reuter, Laura Kühlewein, et al.
Plos One|July 4, 2008
Systemic complement activation in age-related macular degenerationHendrik P N Scholl, Peter Charbel Issa, Maja Walier, et al.
Investigative Ophthalmology & Visual Science|January 1, 2016
Monoallelic ABCA4 Mutations Appear Insufficient to Cause Retinopathy: A Quantitative Autofluorescence StudyPhilipp L Müller, Martin Gliem, Elisabeth Mangold, et al.
The British Journal of Ophthalmology|July 9, 2025
Microbiological sampling has limited value in managing acute postoperative bacterial endophthalmitis: a multicentre study in the UKAriel Yuhan Ong, Boon Lin Teh, Alice Milligan, et al.
Ophthalmology|September 22, 2023
Developing a Continuous Severity Scale for Macular Telangiectasia Type 2 Using Deep Learning and Implications for Disease GradingYue Wu, Catherine Egan, Abraham Olvera-Barrios, et al.
Nature|October 8, 2011
Complement factor H binds malondialdehyde epitopes and protects from oxidative stressDavid Weismann, Karsten Hartvigsen, Nadine Lauer, et al.
Ophthalmic Research|August 16, 2018
The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1)Rupert W Strauss, Beatriz Muñoz, Mohamed I Ahmed, et al.
American Journal of Ophthalmology|September 5, 2024
Multifocal Vitelliform Paravascular Retinopathy (MVPR): A New Disorder in the Vitelliform SpectrumWeilin Song, Sandeep Randhawa, Mark W Johnson, et al.
Frontiers in Medicine|February 14, 2024
Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort studyPeter Kiraly, Immanuel P Seitz, Maram E A Abdalla Elsayed, et al.
Pageof 24

Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Eye (London, England)|October 11, 2024
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedemaGrace A Borchert, Christine A Kiire, Niamh M Stone, et al.
JAMA Ophthalmology|May 26, 2018
Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis PigmentosaPeter Charbel Issa, Peggy Reuter, Laura Kühlewein, et al.
Plos One|July 4, 2008
Systemic complement activation in age-related macular degenerationHendrik P N Scholl, Peter Charbel Issa, Maja Walier, et al.
Investigative Ophthalmology & Visual Science|January 1, 2016
Monoallelic ABCA4 Mutations Appear Insufficient to Cause Retinopathy: A Quantitative Autofluorescence StudyPhilipp L Müller, Martin Gliem, Elisabeth Mangold, et al.
The British Journal of Ophthalmology|July 9, 2025
Microbiological sampling has limited value in managing acute postoperative bacterial endophthalmitis: a multicentre study in the UKAriel Yuhan Ong, Boon Lin Teh, Alice Milligan, et al.
Ophthalmology|September 22, 2023
Developing a Continuous Severity Scale for Macular Telangiectasia Type 2 Using Deep Learning and Implications for Disease GradingYue Wu, Catherine Egan, Abraham Olvera-Barrios, et al.
Nature|October 8, 2011
Complement factor H binds malondialdehyde epitopes and protects from oxidative stressDavid Weismann, Karsten Hartvigsen, Nadine Lauer, et al.
Ophthalmic Research|August 16, 2018
The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1)Rupert W Strauss, Beatriz Muñoz, Mohamed I Ahmed, et al.
American Journal of Ophthalmology|September 5, 2024
Multifocal Vitelliform Paravascular Retinopathy (MVPR): A New Disorder in the Vitelliform SpectrumWeilin Song, Sandeep Randhawa, Mark W Johnson, et al.
Frontiers in Medicine|February 14, 2024
Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort studyPeter Kiraly, Immanuel P Seitz, Maram E A Abdalla Elsayed, et al.
Pageof 24